AXS vs BPOP

AXS exhibits a weak Piotroski F-Score of 2/9, signaling significant financial health concerns, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company trades at a low P/E of 8.53 versus sector average of 20.94, shows strong recent earnings growth (YoY +83.3%), and beats estimates consistently, with a favorable analyst target of $120.91. However, deteriorating technical trend (0/100), bearish insider activity, and weak liquidity ratios (Current Ratio: 0.70, Quick Ratio: 0.19) counterbalance valuation appeal. The stock appears reasonably valued near $102 but faces structural balance sheet risks and negative insider sentiment.

BPOP's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. Despite strong profitability metrics and robust earnings growth, the lack of Altman Z-Score and missing key financial data (Debt/Equity, cash/debt levels) limits confidence in structural safety. The stock trades below analyst target and intrinsic value estimates but faces headwinds from bearish insider activity and weakening technical momentum. Solid dividend coverage and sector-leading earnings surprises provide offsetting positives.